ストックスクリーナーアプリを入手
24.47
2.86%
-0.72
アフターアワーズ：
24.15
-0.32
-1.31%
前日終値:
$25.19
開ける：
$25.02
24時間の取引高:
640.38K
Relative Volume:
0.76
時価総額：
$2.76B
収益：
$14.09M
当期純損益:
$-176.94M
株価収益率:
-11.38
EPS:
-2.15
ネットキャッシュフロー:
$-141.24M
1週間 パフォーマンス:
+0.62%
1か月 パフォーマンス:
+3.69%
6か月 パフォーマンス:
+17.03%
1年 パフォーマンス:
+45.92%
1日の値動き範囲:
$24.12
$25.03
1週間の範囲:
$23.68
$25.65
52週間の値動き範囲:
$14.06
$27.29
Newamsterdam Pharma Company Nv Stock (NAMS) Company Profile
NAMS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NAMS
Newamsterdam Pharma Company Nv
|
24.47 | 2.84B | 14.09M | -176.94M | -141.24M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Newamsterdam Pharma Company Nv Stock (NAMS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-25 | 開始されました | Wells Fargo | Overweight |
| 2025-07-17 | 開始されました | Goldman | Neutral |
| 2025-06-17 | 開始されました | Citigroup | Buy |
| 2025-06-10 | 開始されました | Stifel | Buy |
| 2025-06-04 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-12-30 | 開始されました | H.C. Wainwright | Buy |
| 2024-05-15 | 開始されました | TD Cowen | Buy |
| 2024-03-14 | 開始されました | Scotiabank | Sector Outperform |
| 2024-01-18 | 開始されました | Guggenheim | Buy |
| 2024-01-16 | 開始されました | Piper Sandler | Overweight |
| 2023-10-30 | 開始されました | RBC Capital Mkts | Outperform |
すべてを表示
Newamsterdam Pharma Company Nv (NAMS) 最新ニュース
How sentiment analysis helps forecast NewAmsterdam Pharma Company N.V.Quarterly Market Summary & Risk Controlled Daily Trade Plans - Newser
What earnings revisions data tells us about NewAmsterdam Pharma Company N.V. Equity WarrantPortfolio Performance Summary & Fast Entry High Yield Tips - Newser
Full technical analysis of NewAmsterdam Pharma Company N.V. Equity Warrant stockJuly 2025 Snapshot & Free Low Drawdown Momentum Trade Ideas - Newser
What to expect from NewAmsterdam Pharma Company N.V. in the next 30 daysPortfolio Value Summary & Stepwise Trade Execution Plans - Newser
NewAmsterdam announces acceptance of MAA for review by EMA for obicetrapib - MSN
Predicting NewAmsterdam Pharma Company N.V. trend using moving averagesEarnings Growth Report & Expert Verified Movement Alerts - Newser
What earnings revisions data tells us about NewAmsterdam Pharma Company N.V.Stop Loss & Growth Focused Investment Plans - Newser
Is NewAmsterdam Pharma Company N.V. Equity Warrant a candidate for recovery playQuarterly Profit Review & Free Expert Approved Momentum Trade Ideas - Newser
Price action breakdown for NewAmsterdam Pharma Company N.V. Equity WarrantMarket Growth Summary & Breakout Confirmation Alerts - Newser
How to integrate NewAmsterdam Pharma Company N.V. Equity Warrant into portfolio analysis toolsJuly 2025 Earnings & Reliable Entry Point Alerts - Newser
NewAmsterdam Pharma Company N.V. stock prediction for this weekPortfolio Value Report & Real-Time Volume Analysis Alerts - Newser
Historical volatility pattern of NewAmsterdam Pharma Company N.V. visualizedTrade Analysis Report & Daily Growth Stock Investment Tips - Newser
Using Ichimoku Cloud for NewAmsterdam Pharma Company N.V. Equity Warrant technicalsTake Profit & Weekly High Potential Alerts - Newser
How sentiment analysis helps forecast NewAmsterdam Pharma Company N.V. Equity WarrantWeekly Trade Report & Weekly High Potential Stock Alerts - Newser
Analyzing NewAmsterdam Pharma Company N.V. with risk reward ratio charts2025 Market Sentiment & AI Optimized Trade Strategies - Newser
NewAmsterdam Pharma Company N.V. Equity Warrant stock momentum explainedMarket Activity Report & Risk Controlled Daily Trade Plans - Newser
Short interest data insights for NewAmsterdam Pharma Company N.V.Index Update & Fast Entry High Yield Stock Tips - Newser
Newamsterdam Pharma shares rise 1.86% intraday after insider sold shares. - AInvest
Momentum divergence signals in NewAmsterdam Pharma Company N.V. chart2025 Market Outlook & Daily Stock Momentum Reports - Newser
Real time breakdown of NewAmsterdam Pharma Company N.V. stock performanceGlobal Markets & Risk Adjusted Swing Trade Ideas - Newser
Using R and stats models for NewAmsterdam Pharma Company N.V. forecasting2025 Technical Patterns & Free Expert Approved Momentum Trade Ideas - Newser
What’s the recovery path for long term holders of NewAmsterdam Pharma Company N.V.Weekly Stock Summary & AI Powered Market Entry Ideas - Newser
Comparing NewAmsterdam Pharma Company N.V. Equity Warrant in custom built stock radarsMarket Growth Review & Accurate Technical Buy Alerts - Newser
Published on: 2025-08-25 21:09:41 - beatles.ru
NewAmsterdam Pharma Company N.V. Equity Warrant’s volatility index tracking explainedGlobal Markets & Reliable Intraday Trade Plans - Newser
NewAmsterdam Pharma to Participate in Upcoming Medical Meeting and Investor Conferences in September - GlobeNewswire
Major Phase 3 Data Coming: NewAmsterdam's Novel Cholesterol Drug Results at ESC Congress 2025 - Stock Titan
NewAmsterdam Pharma stock initiated at Overweight by Wells Fargo - Investing.com
Can NewAmsterdam Pharma Company N.V. recover in the next quarterJuly 2025 Levels & Safe Capital Investment Plans - Newser
Does NewAmsterdam Pharma Company N.V. qualify in momentum factor screeningMarket Performance Summary & Risk Controlled Swing Alerts - Newser
Is NewAmsterdam Pharma Company N.V. trending in predictive chart models2025 Investor Takeaways & Safe Capital Growth Plans - Newser
Smart tools for monitoring NewAmsterdam Pharma Company N.V.’s price action - Newser
Institutional scanner results for NewAmsterdam Pharma Company N.V. Equity WarrantPortfolio Value Report & AI Powered Market Trend Analysis - Newser
NewAmsterdam Pharma Company N.V. Chart Enters High Volatility ZoneJuly 2025 Setups & Risk Controlled Stock Pick Alerts - beatles.ru
Short Term Trend Reversal in NewAmsterdam Pharma Company N.V. PossibleJuly 2025 EndofMonth & Expert Verified Stock Movement Alerts - beatles.ru
CDMO Piramal Pharma Solutions NewAmsterdam Pharma Partner To Expand Oral Solid Dosage Production At Sellersville PA Manufacturing Site - Pharmaceutical Online
Is NewAmsterdam Pharma Company N.V. Equity Warrant’s ROE strong enoughJuly 2025 Sector Moves & Daily Volume Surge Trade Alerts - theviewers.co.kr
Can NewAmsterdam Pharma Company N.V. Equity Warrant stock double in the next yearPortfolio Update Report & Fast Entry High Yield Stock Tips - theviewers.co.kr
Piramal, NewAmsterdam Pharma Open Dedicated OSD Form Suite - Contract Pharma
Visual analytics tools that track NewAmsterdam Pharma Company N.V. performanceJuly 2025 News Drivers & Technical Analysis for Trade Confirmation - Newser
Piramal Pharma Solutions and NewAmsterdam Pharma Invest in Dedicated Suite to Enhance Oral Solid Dosage Production Capabilities at Piramal's Sellersville, Pennsylvania Site - Yahoo Finance
Piramal Pharma Solutions and NewAmsterdam Pharma Invest in Dedicated Suite to Enhance Oral Solid Dosage Production Capabilities at Piramal's Sellersville, Pennsylvania Site – Company AnnouncementFT.com - Financial Times
Newamsterdam Pharma Company Nv (NAMS) 財務データ
収益
当期純利益
現金流量
EPS
0.98%
8.06%
大文字化:
|
ボリューム (24 時間):